BlackRock Portfolio holdings
BlackRock is an asset manager that runs the iShares family of exchange-traded funds. It was founded in 1988 by Larry Fink, a mortgage-bond pioneer at First Boston, and several colleagues, to manage money for institutions with a focus on risk. Blackstone backed the start-up in exchange for a stake in its bond business, and the two parted ways in 1994. BlackRock went public in 1999 and merged with the investment managers division of Merrill in 2006. BlackRock bought the iShares business from Barclays in 2010 and the private credit manager HPS Investment Partners in 2025. It also sells technology: its Aladdin platform gives institutional investors tools for portfolio management, risk analysis, trading and accounting, and its BlackRock Solutions unit, launched in 2000, advises on risk management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$8.67B |
| 2 |
Microsoft
MSFT
|
+$5.68B |
| 3 |
HONA
Honeywell Aerospace
HONA
|
+$5.24B |
| 4 |
Apple
AAPL
|
+$5.23B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$5.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$5.81B |
| 2 |
Coterra Energy
CTRA
|
+$2.24B |
| 3 |
Intel
INTC
|
+$2.13B |
| 4 |
Qualcomm
QCOM
|
+$2.03B |
| 5 |
Hologic
HOLX
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Financials | 11.04% |
| 3 | Industrials | 9.8% |
| 4 | Healthcare | 9.52% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2126
IMAX
IMAX
$2.61B
| $116M | ﹤0.01% |
2,907,192
+284,602
| +11% | +$10.9M |
2013 Q2
52 quarters
|
|
2127
Howard Hughes
HHH
$4.64B
| $116M | ﹤0.01% |
1,619,333
+139,898
| +9% | +$9.1M |
2013 Q2
52 quarters
|
|
2128
Scotiabank
BNS
$112B
| $116M | ﹤0.01% |
1,331,905
-171,144
| -11% | -$13.5M |
2019 Q3
27 quarters
|
|
2129
iShares Global Industrials ETF
EXI
$1.35B
| $116M | ﹤0.01% |
576,732
+10,318
| +2% | +$2M |
2013 Q2
52 quarters
|
|
2130
Dillards
DDS
$9.41B
| $115M | ﹤0.01% |
218,316
+30,143
| +16% | +$17.4M |
2013 Q2
52 quarters
|
|
2131
Klarna Group
KLAR
$5.16B
| $115M | ﹤0.01% |
5,698,353
+2,693,374
| +90% | +$42.4M |
2025 Q3
3 quarters
|
|
2132
Kura Oncology
KURA
$647M
| $115M | ﹤0.01% |
10,509,233
+871,702
| +9% | +$8.22M |
2017 Q1
37 quarters
|
|
2133
Vanguard Morningstar Small-Cap ETF
VB
$77.3B
| $115M | ﹤0.01% |
380,254
+12,452
| +3% | +$3.57M |
2015 Q4
42 quarters
|
|
2134
Xeris Biopharma Holdings
XERS
$2.77B
| $115M | ﹤0.01% |
14,525,539
+1,579,754
| +12% | +$10.1M |
2018 Q2
32 quarters
|
|
2135
Klaviyo
KVYO
$5.9B
| $115M | ﹤0.01% |
7,612,078
+3,257,743
| +75% | +$54M |
2023 Q3
11 quarters
|
|
2136
Sabre
SABR
$682M
| $114M | ﹤0.01% |
54,748,696
-1,022,356
| -2% | -$1.79M |
2015 Q2
44 quarters
|
|
2137
First Mid Bancshares
FMBH
$1.35B
| $114M | ﹤0.01% |
2,375,794
+307,643
| +15% | +$13.6M |
2016 Q2
40 quarters
|
|
2138
Bicara Therapeutics
BCAX
$572M
| $114M | ﹤0.01% |
3,848,090
+1,004,383
| +35% | +$22.4M |
2024 Q4
6 quarters
|
|
2139
CEVA Inc
CEVA
$763M
| $114M | ﹤0.01% |
2,417,205
+209,237
| +9% | +$7.4M |
2013 Q2
52 quarters
|
|
2140
TriMas Corp
TRS
$1.39B
| $114M | ﹤0.01% |
2,530,345
+33,302
| +1% | +$1.33M |
2013 Q2
52 quarters
|
|
2141
Willdan Group
WLDN
$1.01B
| $114M | ﹤0.01% |
1,438,623
+120,899
| +9% | +$10.3M |
2016 Q4
38 quarters
|
|
2142
Cardinal Infrastructure Group
CDNL
$312M
| $114M | ﹤0.01% |
1,207,548
+510,349
| +73% | +$29.4M |
2026 Q1
1 quarter
|
|
2143
Wolfspeed
WOLF
$1.26B
| $114M | ﹤0.01% |
2,353,768
+1,892,480
| +410% | +$82.4M |
2013 Q2
52 quarters
|
|
2144
Genco Shipping & Trading
GNK
$1.13B
| $113M | ﹤0.01% |
4,575,438
+682,197
| +18% | +$16.5M |
2017 Q1
37 quarters
|
|
2145
ArriVent BioPharma
AVBP
$673M
| $113M | ﹤0.01% |
3,250,396
+720,095
| +28% | +$21.3M |
2024 Q1
9 quarters
|
|
2146
Marcus & Millichap
MMI
$1.05B
| $113M | ﹤0.01% |
3,618,887
-310,849
| -8% | -$8.91M |
2015 Q2
44 quarters
|
|
2147
BrightSpring Health Services Unit
BTSGU
$1.7B
| $113M | ﹤0.01% |
492,369
-55,116
| -10% | -$10.1M |
2024 Q1
9 quarters
|
|
2148
CALL
KraneShares CSI China Internet ETF
KWEB
$4.63B
| $113M | ﹤0.01% |
+4,599,200
| New | +$127M |
2026 Q2
0 quarters
|
|
2149
Rapport Therapeutics
RAPP
$1.45B
| $113M | ﹤0.01% |
2,699,786
+193,831
| +8% | +$7.12M |
2024 Q3
7 quarters
|
|
2150
Paymentus
PAY
$4.22B
| $112M | ﹤0.01% |
4,643,131
+3,617,383
| +353% | +$88.8M |
2021 Q2
20 quarters
|
|
Similar funds
BlackRock's Q2 2026 Portfolio in Review
As of Q2 2026, BlackRock held 5,933 positions worth $6.73T, up 18% from $5.72T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BlackRock's Q2 2026 filing shows 245 new, 3,464 increased, 1,293 reduced and 235 closed positions. Its largest new stake was SpaceX: 51,037,137 shares worth $8.72B. The largest sale was Honeywell, an estimated $5.81B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.
- BlackRock's largest Q2 2026 buy was SpaceX: 51,037,137 shares worth $8.72B.
- BlackRock added most to Microsoft in Q2 2026, an estimated $5.68B increase.
- BlackRock's biggest Q2 2026 reduction was Honeywell, cutting an estimated $5.81B.
- BlackRock fully exited Coterra Energy in Q2 2026, selling an estimated $2.24B.
- BlackRock's ten largest holdings make up 28% of its $6.73T portfolio in Q2 2026.
- BlackRock opened 245 new positions and closed 235 in Q2 2026.
- BlackRock's portfolio value rose 18% quarter-over-quarter to $6.73T.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.